Suven Life Gets Patent Registered for Neuro-Degenerative Drug - 14.10.2015

Drug firm Suven Life Sciences has been granted patent by Australia, China, Europe, South Korea and the US for a drug used in the treatment of neuro-degenerative diseases. The patents are valid until 2031, 2030, 2031, 2030 and 2031, respectively.

Tags : Suven Life Patent Neuro-Degenerative Drug

Share :